The 3rd World Congress on Genetics, Geriatrics and Neurodegenerative Diseases Research (GeNeDis 2018) will be held in Toronto Canada, from 25 to 28 of October 2018 (www.genedis.eu).
For the third time three of the most modern and popular scientific areas are brought together in a congress, the 3rd World Congress on Genetics, Geriatrics and Neurodegenerative Disease research with the title: “Health Aging and Mental Wellness in the new digital era”. Leading scientists and researchers from all over the world will discuss the recent developments in the above disciplines, ranging from research progress and the latest scientific discoveries to the clinical and pharmaceutical applications.
GeNeDis 2018 will focus on a strong scientific program combined with teaching, training and live workshops to inform and educate scientist on the latest major challenges in scientific research, the new drug targets, the development of novel biomarkers, the new imaging techniques and the novel protocols for early diagnosis of neurodegenerative diseases, and several other scientific advances. GeNeDis 2018 will feature an internationally recognized widely diverse program, that will contribute in attracting delegates to attend this major event.
The goal of the 3rd World Congress GeNeDis 2018 is to strengthen and broaden the international network by sharing the recent advancements in Genetics, Geriatrics and Neuroscience and by establishing good contacts with all relevant stakeholders – all pursuing the excellence in research, development, education and training with the aim of better and safe health aging.
The Institute for Clinical Investigation (ICI), member of Bionian Cluster, is currently looking to fill a Clinical Project Manager position.
JOB DESCRIPTION: Clinical Project Manager
Responsible for the support of assigned sites in accordance with Good Clinical Practice (GCP), ICH guidelines and federal regulations. Close collaboration with other members within Clinical Trial Management (CTM). May be responsible for monitoring assigned sites in accordance with GCP/ICH and SOPs and submitting the proper documentation to the national authorities for approval.
COORDINATION / COMMUNICATION, ADMINISRATION AND PERSONNEL DEVELOPMENT:
Ensure compliance with the application and communication of all company’s policies, procedures and fundamentals.
KEY SUCCESS FACTORS: EDUCATION, EXPERIENCE, KNOWLEDGE AND SKILLS:
• A Bachelor’s/MSc degree is required (science-related discipline strongly preferred, i.e. Pharmacology, Chemical Engineering, Biology etc.).
• A minimum of 3 years of clinical trial experience within pharmaceutical, biotechnology, CRO company and/or healthcare setting.
• Demonstrated computer skills (MS Office, Powerpoint)
• Demonstrates core understanding of medical terminology and clinical trial activities in relation to execution of a clinical development plan.
• Direct expertise of site management and logistical execution of clinical trials for at least 2 years.
• Knowledge of GCP as relates to clinical trial management
• Previous on-site monitoring experience preffered.
• Excellent use of English.
Acting as a Contract Research Organization on behalf of the Biopharma Industry, Academic Centers, Investigators and other Public or Private Bodies, it offers services at any stage of development for marketing authorization of pharmaceutical products.
I.C.I., as a member of the Bionian Cluster, has established collaborations with globally renowned Universities, Research Institutes, state Institutions and Hospitals, a fact that enhances its presence on the international environment of CRO-companies.
The Institute for Clinical Investigation, modeled according to the General Clinical Research Centers in the USA and Europe, operates strictly according to the ICH- GCPs and the current legislation, regulations and guidelines οf the International and National organizations (FDA, MHRA, EMA, EOF). The multidisciplinary and highly skilled personnel of I.C.I. has been endowed with an extensive range of academic titles and qualifications, as well as a broad experience in bioequivalence, pre-clinical and clinical research.
Στο πλαίσιο του πυλώνα εκπαίδευσης Bionian Academy, το Bionian Cluster Βιοτεχνολογίας και Υγείας πραγματοποιεί σεμινάριο σχετικά με τις Σπάνιες Παθήσεις και τα Ορφανά Φάρμακα, διάρκειας δύο ημερών, 10 - 11 Οκτωβρίου 2015, με θέμα: Σπάνια Νοσήματα και Ορφανά Φάρμακα Επί Ενδείξεων Βασιζόμενες Προσεγγίσεις. Οι εργασίες του διήμερου σεμιναρίου θα πραγματοποιηθούν στο Αμφιθέατρο Ελληνικού Ινστιτούτου Pasteur.